Smart science to improve lives™
Pharma
  • Login | Register
Pharma
Scaling beyond limits: our role in pioneering COVID-19 solutions

The race to beat COVID-19

As COVID-19 surged across the world, our team fought against time to get critical materials ready for the world’s leading vaccines.

Decades of driving biopharma forward

winners trophy icon image
Winner of Best Supplier for COVID-19 Vaccine Development 2022 View
white icon graphic of a syringe
Our adjuvants feature in 15 out of 24 WHO listed vaccines View
icon used to represent a gene
Customising lipids since 1950 View

Explore related content:

Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants.

Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

19 May 2023: Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants.

Nucleic Acid delivery croda pharma

Nucleic Acid Delivery

We develop and manufacture innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics

Adjuvant systems

Adjuvant Systems

Your partner for modern vaccine development. Our unique GMP portfolio and outstanding expertise can meet your adjuvant needs. Collaborate with our scientists to create the vaccines of tomorrow.